These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17508041)

  • 1. Modulating the immune system: a vaccine for glaucoma?
    Schwartz M
    Can J Ophthalmol; 2007 Jun; 42(3):439-41. PubMed ID: 17508041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of immune system in glaucomatous optic nerve degeneration].
    Zhang Y; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2007 Sep; 43(9):858-61. PubMed ID: 18070540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune system and glaucoma.
    Tezel G; Wax MB
    Curr Opin Ophthalmol; 2004 Apr; 15(2):80-4. PubMed ID: 15021215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune response in glaucoma: a perspective on the roles of oxidative stress.
    Tezel G
    Exp Eye Res; 2011 Aug; 93(2):178-86. PubMed ID: 20709058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological approaches to neuroprotection. boosting of protective autoimmunity.
    Schwartz M
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S256-60; discussion S273-6. PubMed ID: 11377445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune basis of glaucoma.
    Shazly TA; Aljajeh M; Latina MA
    Semin Ophthalmol; 2011; 26(4-5):278-81. PubMed ID: 21958174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture.
    Schwartz M
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1407-11. PubMed ID: 12657572
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of the Immune System for the Treatment of Glaucoma.
    Bell K; Und Hohenstein-Blaul NVT; Teister J; Grus F
    Curr Neuropharmacol; 2018; 16(7):942-958. PubMed ID: 28730968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glaucoma.
    Tezel G; Wax MB
    Chem Immunol Allergy; 2007; 92():221-227. PubMed ID: 17264498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune mechanisms in molecular pathology of glaucomatous optic neuropathy].
    Maruyama I; Nakazawa M; Ohguro H
    Nippon Ganka Gakkai Zasshi; 2001 Apr; 105(4):205-12. PubMed ID: 11329942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.
    Schwartz M; London A
    Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
    Yamamoto T
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
    Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glaucomatous optic neuropathy: pathogenesis, clinical picture, and new approaches to treatment].
    Kurysheva NI
    Vestn Oftalmol; 2001; 117(6):45-9. PubMed ID: 11845698
    [No Abstract]   [Full Text] [Related]  

  • 16. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies.
    Kipnis J; Yoles E; Porat Z; Cohen A; Mor F; Sela M; Cohen IR; Schwartz M
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7446-51. PubMed ID: 10861010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New insights into the pathogenesis of glaucomatous optic neuropathy and refinement of the objective assessment of its functional damage].
    Nakamura M
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):298-344; discussion 345-6. PubMed ID: 22568105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current concepts in the pathogenesis of glaucomatous optic neuropathy].
    Chmielewska K
    Klin Oczna; 2003; 105(3-4):211-6. PubMed ID: 14552189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicted outcome from hypotensive therapy for glaucomatous optic neuropathy.
    Van Buskirk EM; Cioffi GA
    Am J Ophthalmol; 1993 Nov; 116(5):636-40. PubMed ID: 8238226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.